IDH2 and central nervous system cancer: However, an IDH-wild-type tumor, H3-wild-type, with H3 K27me3 loss, EZHIP overexpression, or EGFR mutation is considered a diffuse glioma, H3 K27-altered, grade 4 (pediatric-type high-grade glioma) [61].